<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01995773</url>
  </required_header>
  <id_info>
    <org_study_id>280278</org_study_id>
    <secondary_id>280278</secondary_id>
    <nct_id>NCT01995773</nct_id>
  </id_info>
  <brief_title>Glucose Metabolism and Quality of Life in Healthy Women</brief_title>
  <acronym>Healthy women</acronym>
  <official_title>Glucose Metabolism, Adrenal Function, Cortisol Metabolism, Body Composition Physical Activity, and Quality of Life in Healthy Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Odense University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Odense University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Polycystic ovary syndrome (PCOS) is a common endocrine disorder in premenopausal women. Women
      with PCOS often have problems with fertility, unwanted hair growth, and irregular menstrual
      cycle. PCOS is associated with obesity, changes in glucose metabolism and low quality of
      life.

      In the present study, hormonal profile, glucose metabolism, adrenal functon, androgen levels,
      cortisol metabolism, anflammatory response, ovarian morphology, body composition, pfysical
      activity and quality of life is studied in 40 healthy women. The results will be compared
      with results from studies on women with PCOS in order to investigate any differences in these
      parametres.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2011</start_date>
  <completion_date type="Actual">June 2013</completion_date>
  <primary_completion_date type="Actual">January 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Level of androgens</measure>
    <time_frame>baseline</time_frame>
    <description>Level of testosterone and sexual hormone binding globuline in blood samples</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>Baseline</time_frame>
    <description>Quality of life measured by validated questionnaires</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body composition</measure>
    <time_frame>baseline</time_frame>
    <description>Body composition measured by full body DXA-scan with estimates on lean body mass and fat mass</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bone density</measure>
    <time_frame>baseline</time_frame>
    <description>Bone density measured by DXA scan of hip and wrist</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glucose tolerance</measure>
    <time_frame>5 hours</time_frame>
    <description>Glucose tolerance measured by 5 hour oral glucose tolerance test with blood glucose measurements for 5 hours after oral intake of 75 g glucose</description>
  </secondary_outcome>
  <other_outcome>
    <measure>physical activity</measure>
    <time_frame>one week</time_frame>
    <description>Physical activity measured by accelerometre</description>
  </other_outcome>
  <other_outcome>
    <measure>adrenal activity</measure>
    <time_frame>1 hour</time_frame>
    <description>Adrenal recativity measured by 1 hour ACTH-stimulation test</description>
  </other_outcome>
  <other_outcome>
    <measure>Ovarian morphology</measure>
    <time_frame>at baseline</time_frame>
    <description>Ovarian morphology described by vaginal ultrasound with measurements of ovarian volumen and description of phollicles.</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">40</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Healthy Controls</arm_group_label>
    <description>Healthy control women</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood and urine samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        40 healthy women with regular menstrual cycle, normal hair growth, and body mass index
        between 18 and 35 kg/m2
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy

          -  No medications

          -  regular menstrual cycle

          -  no hair growth problems

          -  BMI 18-35 kg/m2

        Exclusion Criteria:

          -  medication

          -  diabetes mellitus

          -  signs of PCOS

          -  BMI &lt; 18 or &gt; 35
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hanne Mumm, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Odense University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Odense University Hospital</name>
      <address>
        <city>Odense</city>
        <zip>5000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 21, 2013</study_first_submitted>
  <study_first_submitted_qc>November 26, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 27, 2013</study_first_posted>
  <last_update_submitted>November 26, 2013</last_update_submitted>
  <last_update_submitted_qc>November 26, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 27, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Odense University Hospital</investigator_affiliation>
    <investigator_full_name>Marianne Andersen</investigator_full_name>
    <investigator_title>DMSci</investigator_title>
  </responsible_party>
  <keyword>Healthy women</keyword>
  <keyword>Quality of life</keyword>
  <keyword>Glucose metabolism</keyword>
  <keyword>Adrenal reactivity</keyword>
  <keyword>Physical activity</keyword>
  <keyword>Body Composition</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

